Literature DB >> 17582608

Allergies are associated with reduced pancreas cancer risk: A population-based case-control study in Ontario, Canada.

Ayelet Eppel1, Michelle Cotterchio, Steven Gallinger.   

Abstract

Pancreatic adenocarcinoma is one of the deadliest cancers with mortality rates almost equaling incidence rates. Each year, approximately 3,500 Canadians are diagnosed with this disease. Although somewhat inconsistent, epidemiological studies have found that allergies are associated with a reduced pancreas cancer risk while there appears to be no association with asthma. These associations were evaluated in a population-based case-control study conducted in Ontario. Incident cases of pancreatic adenocarcinoma, identified through the Ontario Cancer Registry (OCR), and diagnosed April 1, 2003 to June 1, 2006, were recruited by the Ontario Pancreas Cancer Study (OPCS). Controls were recruited from the Ontario Familial Colorectal Cancer Registry (OFCCR). Data on 276 cases and 378 controls were available for the current study. Multivariable logistic regression analysis was used to obtain age-adjusted odds ratio (AOR) estimates. Ever having allergies or hayfever was associated with reduced pancreas cancer risk (OR = 0.43, 95% confidence interval (CI): 0.29-0.63). There was no association observed between a history of asthma and pancreas cancer risk. Findings are of great importance to understanding the biological mechanisms involved in pancreas cancer development. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2007        PMID: 17582608     DOI: 10.1002/ijc.22884

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  16 in total

1.  Genetic variants in carcinogen-metabolizing enzymes, cigarette smoking and pancreatic cancer risk.

Authors:  Ji-Hyun Jang; Michelle Cotterchio; Ayelet Borgida; Steven Gallinger; Sean P Cleary
Journal:  Carcinogenesis       Date:  2012-02-02       Impact factor: 4.944

2.  Atopic allergic conditions and pancreatic cancer risk: Results from the Multiethnic Cohort Study.

Authors:  Brian Z Huang; Loic Le Marchand; Christopher A Haiman; Kristine R Monroe; Lynne R Wilkens; Zuo-Feng Zhang; Veronica Wendy Setiawan
Journal:  Int J Cancer       Date:  2018-01-12       Impact factor: 7.396

3.  Immunoglobulin E antibodies from pancreatic cancer patients mediate antibody-dependent cell-mediated cytotoxicity against pancreatic cancer cells.

Authors:  S L Fu; J Pierre; T A Smith-Norowitz; M Hagler; W Bowne; M R Pincus; C M Mueller; M E Zenilman; M H Bluth
Journal:  Clin Exp Immunol       Date:  2008-09       Impact factor: 4.330

Review 4.  Atopy and Specific Cancer Sites: a Review of Epidemiological Studies.

Authors:  Yubao Cui; Andrew W Hill
Journal:  Clin Rev Allergy Immunol       Date:  2016-12       Impact factor: 8.667

Review 5.  Molecular biology of pancreatic cancer.

Authors:  Miroslav Zavoral; Petra Minarikova; Filip Zavada; Cyril Salek; Marek Minarik
Journal:  World J Gastroenterol       Date:  2011-06-28       Impact factor: 5.742

6.  Screening for pancreatic cancer in a high-risk cohort: an eight-year experience.

Authors:  Wigdan Al-Sukhni; Ayelet Borgida; Heidi Rothenmund; Spring Holter; Kara Semotiuk; Robert Grant; Stephanie Wilson; Malcolm Moore; Steven Narod; Kartik Jhaveri; Masoom A Haider; Steven Gallinger
Journal:  J Gastrointest Surg       Date:  2011-11-30       Impact factor: 3.452

7.  Interaction of polymorphisms in mitotic regulator genes with cigarette smoking and pancreatic cancer risk.

Authors:  Ji-Hyun Jang; Michelle Cotterchio; Ayelet Borgida; Geoffrey Liu; Steven Gallinger; Sean P Cleary
Journal:  Mol Carcinog       Date:  2013-06-12       Impact factor: 4.784

8.  Association between allergies and risk of pancreatic cancer.

Authors:  Michelle Cotterchio; Elizabeth Lowcock; Thomas J Hudson; Celia Greenwood; Steven Gallinger
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-02-19       Impact factor: 4.254

9.  Germline BRCA1 mutations predispose to pancreatic adenocarcinoma.

Authors:  Wigdan Al-Sukhni; Heidi Rothenmund; Ayelet Eppel Borgida; George Zogopoulos; Anne-Marie O'Shea; Aaron Pollett; Steven Gallinger
Journal:  Hum Genet       Date:  2008-09-02       Impact factor: 4.132

10.  Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer.

Authors:  Laufey Amundadottir; Peter Kraft; Rachael Z Stolzenberg-Solomon; Charles S Fuchs; Gloria M Petersen; Alan A Arslan; H Bas Bueno-de-Mesquita; Myron Gross; Kathy Helzlsouer; Eric J Jacobs; Andrea LaCroix; Wei Zheng; Demetrius Albanes; William Bamlet; Christine D Berg; Franco Berrino; Sheila Bingham; Julie E Buring; Paige M Bracci; Federico Canzian; Françoise Clavel-Chapelon; Sandra Clipp; Michelle Cotterchio; Mariza de Andrade; Eric J Duell; John W Fox; Steven Gallinger; J Michael Gaziano; Edward L Giovannucci; Michael Goggins; Carlos A González; Göran Hallmans; Susan E Hankinson; Manal Hassan; Elizabeth A Holly; David J Hunter; Amy Hutchinson; Rebecca Jackson; Kevin B Jacobs; Mazda Jenab; Rudolf Kaaks; Alison P Klein; Charles Kooperberg; Robert C Kurtz; Donghui Li; Shannon M Lynch; Margaret Mandelson; Robert R McWilliams; Julie B Mendelsohn; Dominique S Michaud; Sara H Olson; Kim Overvad; Alpa V Patel; Petra H M Peeters; Aleksandar Rajkovic; Elio Riboli; Harvey A Risch; Xiao-Ou Shu; Gilles Thomas; Geoffrey S Tobias; Dimitrios Trichopoulos; Stephen K Van Den Eeden; Jarmo Virtamo; Jean Wactawski-Wende; Brian M Wolpin; Herbert Yu; Kai Yu; Anne Zeleniuch-Jacquotte; Stephen J Chanock; Patricia Hartge; Robert N Hoover
Journal:  Nat Genet       Date:  2009-08-02       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.